Tackling hepatitis C - what PHE modelling shows us Helen Harris BSc PhD FFPH LJWG meeting; November 2014.
DAA ’ s in the treatment of HCV: The Beginning of the end or the end of the beginning for HCV?
Paul Y. Kwo, MD Professor of Medicine Medical Director of Transplantation Division of Medicine/Gastroenterology/ Hepatology Indiana University School of.
